ABOUT BOWEL CANCER

Genetic mutations

Most bowel cancers are not inherited. Around 70% of people diagnosed with bowel cancer have no family history of the disease. However, for some people, family history or inherited genetic factors can increase their risk of developing bowel cancer.

There are several inherited genetic conditions linked to an increased risk of bowel cancer, including:

  • Lynch syndrome
  • Familial adenomatous polyposis (FAP)
  • MYH-associated polyposis (MAP)

Hereditary links

Having a family history of bowel cancer does not necessarily mean you have an inherited genetic condition.

Generally, the more people in a family who have been diagnosed with bowel cancer, and the younger they were when diagnosed, the greater the possibility that there may be a hereditary link.

If you have a strong family history of bowel cancer, talk to your GP. They can discuss your family history with you and whether genetic counselling or further assessment may be appropriate.

Bowel Cancer NZ

Lynch syndrome

Lynch syndrome is an inherited genetic condition that increases the risk of developing bowel cancer and some other cancers. It is one of the most common hereditary cancer syndromes.

If a parent has Lynch syndrome, each of their children has a 50% chance of inheriting the genetic change.

For people with Lynch syndrome, regular bowel surveillance with colonoscopy is recommended to start from around 25 years of age. The frequency of surveillance will depend on your individual history and the findings from your colonoscopies.

Read more about Lynch syndrome.

Familial adenomatous polyposis (FAP)

Familial adenomatous polyposis (FAP) is a rare inherited condition that causes hundreds or sometimes thousands of polyps to develop in the large bowel. These polyps can begin developing during adolescence and are associated with a very high risk of bowel cancer.

Genetic testing can be used to look for changes in the APC gene associated with FAP. A colonoscopy can also be used to identify polyps in the bowel.

If a parent has FAP, each of their children has a 50% chance of inheriting the genetic change.

People with FAP require regular surveillance from a young age. Screening using colonoscopy generally commences around the age of 12-15 for children of those with FAP. Because of the high risk of bowel cancer, surgery to remove part or all of the colon may also be recommended, often during the late teens or early twenties.

Your healthcare team will discuss the appropriate surveillance and treatment with you based on your individual circumstances.

MYH-associated polyposis (MAP)

MYH-associated polyposis (MAP) is a rare inherited condition that can cause multiple polyps to develop in the large bowel and is associated with an increased risk of bowel cancer.

Unlike FAP, a person needs to inherit a genetic change from both parents to develop MAP. If both parents carry the genetic change, each of their children has a 25% chance of developing the condition.

Genetic testing for MAP may also be considered when FAP is suspected but testing does not identify the genetic change associated with FAP.

People diagnosed with MAP may require regular bowel surveillance to help identify and remove polyps and detect bowel cancer early. Your healthcare team can advise you on the surveillance recommended for you.

Genetic counselling

Knowing your family history of bowel cancer and other cancers can help healthcare professionals understand whether you may have an increased risk.

If you have a strong family history of bowel cancer, talk to your GP. They may refer you to a genetic service for further assessment.

A genetic counsellor will talk with you about your family history, including who in your family has had cancer, the type of cancer they had and how old they were when diagnosed. Genetic testing may also be recommended.

If you’re found to have an increased risk of bowel cancer, you may be referred to a specialist to discuss appropriate screening or surveillance for you and your family.

Access to genetic assessment, screening and surveillance may depend on eligibility criteria and the availability of services in your area.

Find out more about the New Zealand Familial Gastrointestinal Cancer Service.